Extensive household outbreak of urinary tract infection and intestinal colonization due to extended-spectrum β-lactamase-producing Escherichia coli sequence type 131

Clinical Infectious Diseases

Volumn 61, Issue 1, 2015, Pages e5-e12

  Madigan, Theresa ^a   Johnson, James R ^b,c   Clabots, Connie ^b,c   Johnston, Brian D ^b,c   Porter, Stephen B ^b,c   Slater, Billie S ^b,c   Banerjee, Ritu ^a  

^a MAYO CLINIC   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

E. coli; ESBL; ST131

Indexed keywords

AMPICILLIN; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; NALIDIXIC ACID; NITROFURANTOIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; STREPTOMYCIN; SULTAMICILLIN; TETRACYCLINE; BETA LACTAMASE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GENOTYPE; HOUSEHOLD; HUMAN; INFANT; INTESTINE; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; URINARY TRACT INFECTION; URINE CULTURE; ANIMAL; CASE REPORT; CLASSIFICATION; CLUSTER ANALYSIS; DOG; ENZYMOLOGY; EPIDEMIC; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FAMILY HEALTH; FAMILY SIZE; FECES; GENETICS; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SECRETION (PROCESS); URINARY TRACT INFECTIONS;

ANIMALS; BETA-LACTAMASES; CARRIER STATE; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DISEASE OUTBREAKS; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FAMILY CHARACTERISTICS; FAMILY HEALTH; FECES; FEMALE; GENOTYPE; HUMANS; INFANT; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 84953887912     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ273     Document Type: Article

References (24)

1. Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: "The other bad E. coli." J Lab Clin Med 2002; 139: 155-62.
2. Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli ST131. Antimicrob Agents Chemother 2014; 58: 4997-5004.
3. Johnson JR, Clabots C. Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin Infect Dis 2006; 43: e101-8.
4. Foxman B, Manning SD, Tallman P, et al. Uropathogenic Escherichia coli are more likely than commensal E. coli to be shared between heterosexual sex partners. Am J Epidemiol 2002; 156: 1133-40.
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI document M100-S21. Wayne, PA: CLSI, 2011.
6. Clermont O, Christenson JK, Denamur E, Gordon DM. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep 2013; 5: 58-65.
7. Johnson JR, Tchesnokova V, Johnston B, et al. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis 2013; 207: 919-28.
8. Colpan A, Johnston B, Porter S, et al. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clin Infect Dis 2013; 57: 1256-65.
9. Bidet P, Metais A, Mahjoub-Messai F, et al. Detection and identification by PCR of a highly virulent phylogenetic subgroup among extraintestinal pathogenic Escherichia coli B2 strains. Appl Environ Microbiol 2007; 73: 2373-7.
10. Clermont O, Christenson JK, Daubie AS, Gordon DM, Denamur E. Development of an allele-specific PCR for Escherichia coli B2 sub-typing, a rapid and easy to perform substitute of multilocus sequence typing. J Microbiol Methods 2014; 101: 24-7.
11. Johnson JR, Urban C, Weissman SJ, et al. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25: H4) and blaCTX-M-15 among extended-spectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother 2012; 56: 2364-70.
12. Johnson JR, Nicolas-Chanoine MH, DebRoy C, et al. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 2012; 18: 598-607.
13. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181: 261-72.
14. Johnson JR, Murray AC, Gajewski A, et al. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother 2003; 47: 2161-8.
15. Woods KL, Johnson JR, Padkowsky S, et al. Community-associated Escherichia coli harboring CTX-M beta-lactamases from urine cultures from pediatric patients. Antimicrob Agents Chemother 2012; 56: 2209-10.
16. Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 2014; 27: 543-74.
17. Price LB, Johnson JR, Aziz M, et al. The epidemic of extended-spectrum-beta-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio 2013; 4: e00377-13.
18. Vimont S, Boyd A, Bleibtreu A, et al. The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One 2012; 7: e46547.
19. Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol 2013; 34: 361-9.
20. Fornasini M, Reves RR, Murray BE, Morrow AL, Pickering LK. Trimethoprim-resistant Escherichia coli in households of children attending day care centers. J Infect Dis 1992; 166: 326-30.
21. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010; 51: 286-94.
22. Olesen B, Hansen DS, Nilsson F, et al. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark. J Clin Microbiol 2013; 51: 1779-85.
23. Lavigne JP, Vergunst AC, Goret L, et al. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 2012; 7: e34294.
24. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 2012; 80: 1554-62.